Epilepsies, Partial: all 255 studies

Page 3 of 3. Open to participants first (48), then studies with results posted, then the rest; newest registration first within each.

• An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.CompletedNCT00991757Phase 3
• Safety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial EpilepsyWithdrawnNCT00982787Phase 2
• Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy PatientsCompletedNCT00918047Phase 1
• Improving Lesion Detection in Children With Magnetic Resonance Imaging (MRI)-Negative Partial Epilepsy Using Diffusion Tensor ImagingCompletedNCT00894478
• Genetic Basis of Idiopathic Focal Epilepsies With Cognitif DeficitsStatus unknownNCT00851331Not applicable
• An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset SeizuresCompletedNCT00744731Phase 3
• A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.CompletedNCT00740623Phase 3
• Language Mapping in Patients With EpilepsyCompletedNCT00706160
• Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in EpilepsyCompletedNCT00643500Phase 4
• A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and SeizuresCompletedNCT00643136Phase 3
• Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial EpilepsyCompletedNCT00630357Phase 4
• Epilepsy Phenome/Genome ProjectCompletedNCT00552045
• A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.CompletedNCT00433667Phase 3
• A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.CompletedNCT00425282Phase 3
• A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset SeizuresWithdrawnNCT00422110Phase 2/3
• EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial EpilepsyTerminatedNCT00391534Phase 3
• A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset SeizuresCompletedNCT00280696Phase 3
• Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial SeizuresCompletedNCT00275925Phase 4
• Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial SeizuresCompletedNCT00275912Phase 4
• A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of EpilepsyCompletedNCT00266604Phase 4
• Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.CompletedNCT00245713Phase 4
• Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy PatientsCompletedNCT00236886Phase 3
• A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.CompletedNCT00236873Phase 2
• A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset SeizuresCompletedNCT00236860Phase 2
• A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.CompletedNCT00236847Phase 2
• A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With EpilepsyCompletedNCT00236743Phase 3
• A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control EpilepsyCompletedNCT00236730Phase 2
• A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.CompletedNCT00236691Phase 2
• A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent EpilepsyCompletedNCT00231556Phase 3
• A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset SeizureCompletedNCT00230698Phase 3
• Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial SeizuresTerminatedNCT00215215Phase 4
• Pilot Trial of a Behavioral Treatment for EpilepsyCompletedNCT00212745Phase 1/2
• An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With EpilepsyCompletedNCT00210652Phase 2
• An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With EpilepsyCompletedNCT00210522Phase 2
• A Study of Brivaracetam in Subjects With Partial Onset SeizuresCompletedNCT00175929Phase 2
• A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.CompletedNCT00175890Phase 3
• Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With EpilepsyCompletedNCT00160628Phase 3
• Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POSCompletedNCT00152373Phase 3
• Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial SeizuresCompletedNCT00151879Phase 2/3
• Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.CompletedNCT00150293Phase 3
• Pregabalin Open-Label Extension Trial in Patients With Partial SeizuresCompletedNCT00143143Phase 3
• To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.CompletedNCT00141414Phase 2
• To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial SeizuresCompletedNCT00141388Phase 3
• To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.CompletedNCT00141336Phase 3
• To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.CompletedNCT00141245Phase 3
• Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset SeizuresCompletedNCT00113815Phase 3
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial SeizuresCompletedNCT00113165Phase 3
• A 19-week Cognition Study of Levetiracetam in Children With Partial Onset SeizuresCompletedNCT00105040Phase 2
• MRI in Autosomal Dominant Partial Epilepsy With Auditory FeaturesCompletedNCT00072813
• Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG RecordingsCompletedNCT00071305
• A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in ChildrenTerminatedNCT00067431Phase 3
• Pediatric Epilepsy StudyCompletedNCT00050934Phase 3
• Serotonin Receptors in Seizure DisordersCompletedNCT00001932
• Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial EpilepsyCompletedNCT00001666
• Metabolic Abnormalities in Children With EpilepsyCompletedNCT00001325

← Epilepsies, Partial overview